Contact Us

Levaquin
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

J&J Did not Warn Levaquin Riskier Than Rivals, Lawyer Argues


J&J Did not Warn Levaquin Riskier Than Rivals, Lawyer Argues

Published October 12, 2011 | Bloomberg Business Week

A Johnson & Johnson unit never warned users of the Levaquin antibiotic that it posed a greater risk of tendon damage than rival medications, a lawyer for two men suing the company said today.

Executives of J&J’s Ortho-McNeil-Janssen Pharmaceutical unit sought to protect sales by omitting information about Levaquin’s “comparative risk” from its warning label, Andy a lawyer for Paul Gaffney and Robert Beare, said in closing arguments in the trial of their lawsuits against the drugmaker.

“They should be held to account for not fully disclosing” that they knew Levaquin generated a higher number of reports of Achilles tendon injuries than competing antibiotics, told a state court jury in Atlantic City, New Jersey, today.

Read More: Levaquin Side Effects Trial



 

J&J Did not Warn Levaquin Riskier Than Rivals, Lawyer ArguesRSS Feed
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo